🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Brainsway Ltd (BWAY)

Currency in USD
Real-time Data

BWAY Comments

we may see 10 again....
BWAY VS STIM These two companies use magnetic stimulation to treat various diseases of the brain. Brainsway (BWAY) from Israel and Neuronetics (STIM) from the USA. Brainsway uses deep TMS stimulation and Neuronetics uses superficial stimulation. The deep TMS is more effective. Neuronetics has FDA approval for the treatment of resistant depression and bipolar disorder. Brainsway has FDA approval to treat persistent depression, obsessive-compulsive disorder, and smoking cessation. Brainsway is awaiting the completion of the study and FDA approval for opiate rehab which is a game-changer in this area. The value of the STIM share has risen by more than 550% in the last six months, while the value of Brainsway has risen by only about 65%. (Brainsway is traded for a relatively short time on NASDAQ but for many years on the Tel Aviv Stock Exchange) Brainsway seems to be next in line to jump in price.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.